See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $445B | 7.3x | 17.0x | |
| $369B | 4.3x | 15.6x | |
| $243B | 4.7x | 19.8x | |
| $166B | 2.5x | 11.3x | |
| $86.8B | 1.6x | 7.8x | |
| $75.4B | 3.7x | 15.3x | |
| $66.0B | 3.5x | 12.6x | |
| $60.4B | 8.4x | 36.8x | |
| $54.8B | 3.7x | 14.8x | |
| $49.7B | 3.4x | 23.3x | |
| $47.1B | 9.2x | 40.0x | |
| $41.9B | 4.5x | 18.5x | |
| $41.3B | 2.7x | 12.4x | |
| $33.5B | 1.4x | 7.7x | |
| $32.3B | 2.7x | 17.7x | |
| $23.9B | 3.9x | 17.0x | |
| $23.1B | 1.5x | 8.3x | |
| $22.2B | 1.9x | 11.1x | |
| $22.1B | 2.1x | 6.2x | |
| $17.3B | 1.6x | 10.8x | |
| $13.9B | 8.3x | 40.2x | |
| $12.7B | 2.1x | 14.3x | |
| $11.9B | 2.1x | 10.1x | |
| $10.5B | 7.5x | 41.8x | |
| $10.1B | 6.6x | 26.2x | |
| $9.7B | 6.7x | 35.9x | |
| $8.5B | 1.4x | 8.0x | |
| $8.3B | 1.4x | 13.3x | |
| $7.0B | 1.2x | 6.8x | |
| $6.5B | 6.6x | 25.7x | |
| $6.2B | 9.3x | 29.1x | |
| $6.2B | 4.1x | 20.4x | |
| $5.3B | 1.2x | 7.2x | |
| $5.2B | 2.5x | 13.9x | |
| $4.7B | 1.6x | 10.8x | |
| $4.2B | 8.6x | 33.6x | |
| $4.2B | 1.5x | 6.3x | |
| $4.1B | 3.7x | 11.3x | |
| $4.1B | 1.2x | 7.0x | |
| $4.0B | 9.5x | 28.9x | |
| $3.9B | 1.3x | 7.8x | |
| $3.7B | 3.1x | 19.1x | |
| $3.6B | 2.2x | 12.1x | |
| $3.6B | 1.7x | 10.3x | |
| $3.4B | 4.0x | 9.8x | |
| $3.0B | 2.0x | 10.0x | |
| $2.9B | 0.8x | 5.3x | |
| $2.9B | 1.3x | 9.6x | |
| $2.9B | 8.6x | 32.2x | |
| $2.8B | 0.6x | 5.3x | |
| $2.6B | 1.0x | 7.8x | |
| $2.6B | 1.1x | 5.5x | |
| $2.4B | 2.4x | 10.5x | |
| $2.3B | 0.5x | 6.6x | |
| $2.3B | 5.9x | 17.1x | |
| $2.3B | 5.2x | 19.8x | |
| $2.2B | 2.7x | 19.5x | |
| $2.1B | 3.7x | 18.4x | |
| $2.1B | 0.9x | 6.9x | |
| $2.0B | 1.8x | 13.1x | |
| $1.9B | 2.6x | 13.2x | |
| $1.9B | 2.4x | 11.9x | |
| $1.9B | 1.1x | 9.8x | |
| $1.8B | 2.6x | 12.3x | |
| $1.7B | 6.4x | 18.0x | |
| $1.6B | 0.9x | 7.0x | |
| $1.6B | n/a | n/a | |
| $1.5B | 1.2x | 8.3x | |
| $1.5B | 0.7x | 8.0x | |
| $1.4B | 0.8x | 6.4x | |
| $1.3B | 1.7x | 7.3x | |
| $1.3B | 0.6x | 5.9x | |
| $1.1B | 2.7x | 12.2x | |
| $1.1B | 1.5x | 10.1x | |
| $975M | 1.2x | 6.6x | |
| $966M | 7.6x | 28.7x | |
| $933M | 3.8x | 54.1x | |
| $926M | 0.8x | 7.7x | |
| $891M | 1.9x | 9.4x | |
| $718M | n/a | n/a | |
| $653M | n/a | n/a | |
| $602M | 1.4x | 8.5x | |
| $580M | 0.4x | n/a | |
| $568M | 0.2x | 1.3x | |
| $563M | 0.8x | 6.4x | |
| $551M | 3.2x | 12.9x | |
| $520M | 0.7x | 3.5x | |
| $512M | n/a | n/a | |
| $439M | 1.5x | -20.8x | |
| $398M | 2.0x | -43.4x | |
| $395M | 1.4x | 18.0x | |
| $387M | n/a | n/a | |
| $356M | 1.2x | 9.6x | |
| $347M | n/a | n/a | |
| $335M | 0.8x | 9.5x | |
| $296M | n/a | n/a | |
| $288M | 5.6x | 21.5x | |
| $224M | n/a | n/a | |
| $222M | 0.6x | 10.1x | |
| $201M | 0.4x | 11.9x | |
| $200M | 2.4x | 14.1x | |
| $198M | 1.0x | 9.7x | |
| $192M | n/a | n/a | |
| $188M | 1.3x | 5.8x | |
| $168M | 0.8x | 3.7x | |
| $156M | 0.8x | 5.7x | |
| $153M | 0.6x | 6.2x | |
| $140M | 2.2x | 8.1x | |
| $139M | n/a | n/a | |
| $128M | 0.5x | 5.9x | |
| $84.6M | n/a | n/a | |
| $59.5M | 2.3x | 9.7x | |
| $58.1M | 0.3x | 6.1x | |
| $45.7M | 1.0x | n/a | |
| $41.8M | n/a | n/a | |
| $41.2M | n/a | n/a | |
| $39.8M | n/a | n/a | |
| $28.9M | n/a | n/a | |
| $28.5M | n/a | n/a | |
| $26.8M | 2.2x | n/a | |
| $23.8M | n/a | n/a | |
| $20.2M | 1.1x | -12.0x | |
| $17.7M | n/a | n/a | |
| $13.7M | n/a | n/a | |
| $8.5M | n/a | n/a | |
| $6.6M | n/a | n/a | |
| $5.4M | n/a | n/a | |
| $1.2M | n/a | n/a | |
| -$31.6M | -0.1x | -52.6x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty